# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wedbush analyst Laura Chico maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $35 to $31.
Morgan Stanley analyst Matthew Harrison maintains Pharvaris (NASDAQ:PHVS) with a Overweight and maintains $34 price target.
Morgan Stanley analyst Matthew Harrison maintains Pharvaris (NASDAQ:PHVS) with a Overweight and lowers the price target from...
- SEC Filing
JMP Securities analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price tar...
Wedbush analyst Laura Chico reiterates Pharvaris (NASDAQ:PHVS) with a Outperform and maintains $35 price target.
Pharvaris (NASDAQ:PHVS) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.58) b...
Fourth Quarter and Full Year 2023 Financial Results